These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27107267)

  • 1. HACE1 is a putative tumor suppressor gene in B-cell lymphomagenesis and is down-regulated by both deletion and epigenetic alterations.
    Bouzelfen A; Alcantara M; Kora H; Picquenot JM; Bertrand P; Cornic M; Mareschal S; Bohers E; Maingonnat C; Ruminy P; Adriouch S; Boyer O; Dubois S; Bastard C; Tilly H; Latouche JB; Jardin F
    Leuk Res; 2016 Jun; 45():90-100. PubMed ID: 27107267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous epigenetic regulation of HACE1 in Burkitt- Lymphoma-derived cells.
    Bouzelfen A; Kora H; Alcantara M; Bertrand P; Latouche JB; Jardin F
    Leuk Res; 2017 Sep; 60():53-57. PubMed ID: 28651105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HACE1 is a tumor suppressor gene candidate in natural killer cell neoplasms.
    Küçük C; Hu X; Iqbal J; Gaulard P; Klinkebiel D; Cornish A; Dave BJ; Chan WC
    Am J Pathol; 2013 Jan; 182(1):49-55. PubMed ID: 23142381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of the Tumor Suppressor HACE1 Contributes to Cancer Progression.
    Li JC; Chang X; Chen Y; Li XZ; Zhang XL; Yang SM; Hu CJ; Zhang H
    Curr Drug Targets; 2019; 20(10):1018-1028. PubMed ID: 30827236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney.
    Anglesio MS; Evdokimova V; Melnyk N; Zhang L; Fernandez CV; Grundy PE; Leach S; Marra MA; Brooks-Wilson AR; Penninger J; Sorensen PH
    Hum Mol Genet; 2004 Sep; 13(18):2061-74. PubMed ID: 15254018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers.
    Zhang L; Anglesio MS; O'Sullivan M; Zhang F; Yang G; Sarao R; Mai PN; Cronin S; Hara H; Melnyk N; Li L; Wada T; Liu PP; Farrar J; Arceci RJ; Sorensen PH; Penninger JM
    Nat Med; 2007 Sep; 13(9):1060-9. PubMed ID: 17694067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HACE1, a potential tumor suppressor gene on 6q21, is not involved in extranodal natural killer/T-cell lymphoma pathophysiology.
    Sako N; Dessirier V; Bagot M; Bensussan A; Schmitt C
    Am J Pathol; 2014 Nov; 184(11):2899-907. PubMed ID: 25203537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas.
    Duan H; Heckman CA; Boxer LM
    Mol Cell Biol; 2005 Mar; 25(5):1608-19. PubMed ID: 15713621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-suppressive role of HACE1 in hepatocellular carcinoma and its clinical significance.
    Gao ZF; Wu YN; Bai ZT; Zhang L; Zhou Q; Li X
    Oncol Rep; 2016 Dec; 36(6):3427-3435. PubMed ID: 27805249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant methylation of the HACE1 gene is frequently detected in advanced colorectal cancer.
    Hibi K; Sakata M; Sakuraba K; Shirahata A; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
    Anticancer Res; 2008; 28(3A):1581-4. PubMed ID: 18630515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HACE1 blocks HIF1α accumulation under hypoxia in a RAC1 dependent manner.
    Turgu B; Zhang F; El-Naggar A; Negri GL; Kogler M; Tortola L; Johnson F; Ng T; Li A; Yapp D; Lockwood W; Martinez D; Maris JM; Daugaard M; Penninger JM; Hughes CS; Sorensen PH
    Oncogene; 2021 Mar; 40(11):1988-2001. PubMed ID: 33603169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas.
    Mestre-Escorihuela C; Rubio-Moscardo F; Richter JA; Siebert R; Climent J; Fresquet V; Beltran E; Agirre X; Marugan I; Marín M; Rosenwald A; Sugimoto KJ; Wheat LM; Karran EL; García JF; Sanchez L; Prosper F; Staudt LM; Pinkel D; Dyer MJ; Martinez-Climent JA
    Blood; 2007 Jan; 109(1):271-80. PubMed ID: 16960149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of p21(waf1/cip1) and p27(Kip1) in HDACi-mediated tumor cell death and cell cycle arrest in the Eμ-myc model of B-cell lymphoma.
    Newbold A; Salmon JM; Martin BP; Stanley K; Johnstone RW
    Oncogene; 2014 Nov; 33(47):5415-23. PubMed ID: 24292681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid receptor coactivator-3 is a pivotal target of gambogic acid in B-cell Non-Hodgkin lymphoma and an inducer of histone H3 deacetylation.
    Zhao Z; Zhang X; Wen L; Yi S; Hu J; Ruan J; Zhao F; Cui G; Fang J; Chen Y
    Eur J Pharmacol; 2016 Oct; 789():46-59. PubMed ID: 27370960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
    Qiu GH; Tan LK; Loh KS; Lim CY; Srivastava G; Tsai ST; Tsao SW; Tao Q
    Oncogene; 2004 Jun; 23(27):4793-806. PubMed ID: 15122337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells.
    Lee SH; Kim J; Kim WH; Lee YM
    Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.
    Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H
    Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Romidepsin and Azacitidine Synergize in their Epigenetic Modulatory Effects to Induce Apoptosis in CTCL.
    Rozati S; Cheng PF; Widmer DS; Fujii K; Levesque MP; Dummer R
    Clin Cancer Res; 2016 Apr; 22(8):2020-31. PubMed ID: 26660520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Basis for the Enzymatic Activity of the HACE1 HECT-Type E3 Ligase Through N-Terminal Helix Dimerization.
    Singh S; Machida S; Tulsian NK; Choong YK; Ng J; Shankar S; Liu Y; Chandiramani KV; Shi J; Sivaraman J
    Adv Sci (Weinh); 2023 Sep; 10(27):e2207672. PubMed ID: 37537642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.